NEWS Dr. Nina Mörsch | 07 May 2024 Penicillin allergies are less prevalent than often presumed. However, misdiagnosed allergies can prove detrimental to patients requiring antibiotic therapy and contribute to antibiotic resistance. Professor Norma Jung from the University Hospital Cologne, Germany, presented a new recommendation at the 130th Congress of the German Society for Internal...
Month: <span>May 2024</span>
Post
Asynchronous Primary Care Offers Challenges, Opportunities
Medscape Medical News > Conference News > SGIM 2024 Lara Salahi May 17, 2024 BOSTON — Online patient portals have shifted patient expectations of how quickly clinicians respond and provide timely care, which can lead to burnout. But asynchronous care can, in some cases, be compensated and increase physician productivity and enhance patient care, according...
Post
Thyroid Ablation Safety Addressed by Expert Consensus
News > Medscape Medical News Nancy A. Melville September 19, 2023 With ever-expanding treatment options for the ablation of benign thyroid nodules, the American Thyroid Association (ATA) has issued an expert consensus statement that addresses the safe implementation and utilization of the techniques. “There are no documents to date in the United States focusing primarily...
Post
Study Suggests Inappropriate Use of Thyroid Ultrasounds
Medscape Medical News Miriam E. Tucker DISCLOSURES | December 18, 2023 Nearly three quarters of dedicated thyroid ultrasounds don’t identify biopsy-recommended nodules, and over a third don’t identify any nodules, new research finds. “The number of thyroid ultrasounds performed in the United States has increased fivefold since 2002. This substantial increase produces a significant strain...
Post
Prostate Cancer Screening: What Does Your Patient Fear Most?
Neil Skolnik, MD DISCLOSURES | May 22, 2024 I’m Dr Neil Skolnik, and today I’m going to talk about the American Urological Association’s (AUA’s) guideline on the early detection of prostate cancer. This guideline gives us the opportunity to revisit prostate cancer screening with prostate-specific antigen (PSA). Before I go over the recommendations, I want...
Post
Experimental obesity drug packs double punch to reduce weight
Test of weight-loss candidate in mice shows that there is still room for improvement in a burgeoning field. By Asher Mullard Researchers adapted a peptide similar to the one used in the obesity drug Wegovy to have an even more potent weight-loss response in mice.Credit: Lise Aaserud/NTB/Alamy With obesity drugs now helping people to slim...
Post
How to kill the ‘zombie’ cells that make you age
NEWS FEATURE15 May 2024 By Carissa Wong Researchers are using new molecules, engineered immune cells and gene therapy to kill senescent cells and treat age-related diseases. Illustration: Paweł Jońca Lurking throughout your body, from your liver to your brain, are zombie-like entities known as senescent cells. They no longer divide or function as they once...
Post
Genetic Cause of Rare Neurological Disease Found After 25-Year Search
HEALTH 15 May 2024ByDAVID NIELD Brain tissue scan, with the bright red ring showing a protein clump that only shows up in patients with SCA4. (Mandi Gandelman) You might not have heard of spinocerebellar ataxia type 4 (SCA4), as it’s an incredibly rare condition – but after a quarter of a century of looking, the...
Post
Gene editing breakthrough could soon cure herpes for good
(© DOC RABE Media – stock.adobe.com)HEALTH & MEDICAL NEWS by Chris Melore MAY 14, 2024 SEATTLE — A revolutionary new treatment may forever get rid of the painful and embarrassing blisters that come from a herpes flare-up. The herpes viruses that cause either cold sores around the mouth or blisters near the genitals stick around...
Post
Two Novel Epilepsy Treatments Headed for Pivotal Trials
MDedge News >Conference News > AAN 2024 Ted Bosworth May 14, 2024 Two Novel Epilepsy Treatments Headed for Pivotal Trials DENVER — Two new drugs are headed toward pivotal trials after making their endpoints in phase 2 treatment-resistant epilepsy studies, while a first-in-humans study of an implantable product suggests a new direction for this disease,...